SKYE

Skye Bioscience, Inc.

Healthcare · Biotechnology

$54.14 sample

-0.85 (-1.55%) 1D

Market cap

$180.7B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-28

Alerts

8

Price$54.14 +8.98% 3M daily closessample

55.8249.68

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 05INSInsider sell: 10% owner
Sep 28SECForm 144 filed
Sep 21INSInsider sell: General Counsel
Sep 10INSInsider sell: Director
Sep 03INSInsider sell: Chief Executive Officer
Aug 28INSInsider sell: Chief Executive Officer
Aug 21SECDEF 14A filed
Aug 18INSInsider buy: General Counsel

Sign up to see the real SKYE record →

Company facts

SEC EDGAR registration

Name: Skye Bioscience, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -12sample, -100 to +100
Reporting currency: USD

Who is positioning in SKYE

sample

Insiders: 15 insider transactions over 90 days, net selling, $598.8M
Congress: 2 members traded over 90 days
Institutions · 13F: 14 funds hold $4.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.3B +21.6% y/y

Q4 2024Q3 2026

Inventory$4.3B +9.6% y/y

Q4 2024Q3 2026

Accounts receivable$3.1B +5.2% y/y

Q4 2024Q3 2026

Total debt$8.8B +17.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $74.8B +10.4% 3M
Sample peer B: $168.8B -4.8% 3M
Sample peer C: $36.9B -1.9% 3M
Sample peer D: $93.9B +11.0% 3M
Sample peer E: $89.4B +11.0% 3M